Actively Recruiting
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Led by Ruijin Hospital · Updated on 2023-05-23
20000
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the targeted risk population in China.
CONDITIONS
Official Title
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary participation with signed informed consent and ability to complete all study procedures
- Age between 18 and 75 years old
- Diagnosis of chronic hepatitis B with persistent positive hepatitis B surface antigen for 6 months or more
- Diagnosis of chronic hepatitis C
- Diagnosis of liver cirrhosis confirmed by biopsy, liver stiffness measurement, imaging, APRI score, or FIB-4 score
- Diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD) with liver fibrosis score F3 or higher by transient elastography
- MAFLD diagnosis requires >5% liver fat accumulation plus overweight/obesity, type 2 diabetes, or metabolic dysfunction
- Diagnosis of MAFLD combined with abnormal glucose metabolism including type 2 diabetes, prediabetes, or elevated glycated hemoglobin
- Family history of liver cancer in first-degree biological relatives
You will not qualify if you...
- Age under 18 years or over 75 years
- Previous diagnosis of liver cancer
- Severe mental illness or cognitive impairment
- Pregnant, lactating, or planning pregnancy
- Participation in other clinical trials within 3 months prior to study treatment
- Judged by doctor as unable to understand study, poor compliance, infirmity, or other factors making the subject unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Infectious Diseases , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
Q
Qing Xie, MD
CONTACT
H
Honglian Gui, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here